Croatian National Data and Comparison with European Practice: Data from the Cardiac Resynchronization Therapy Survey II Multicenter Registry
Autor: | Šime Manola, Zlatko Čubranić, Ante Anic, Nikola Pavlović, Camilla Normand, Marina Klasan, Cecilia Linde, Ivan Zeljković, Zrinka Jurišić, Sandro Brusich, David Židan, Kenneth Dickstein |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2018 |
Předmět: |
medicine.medical_specialty
lcsh:Diseases of the circulatory (Cardiovascular) system Article Subject medicine.medical_treatment education Population Cardiac resynchronization therapy 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Internal medicine medicine 030212 general & internal medicine Cardiac Resynchronization Therapy Croatia Adverse effect BIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences. Internal Medicine Reimbursement BIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti. Interna medicina Croatian education.field_of_study Left bundle branch block business.industry medicine.disease language.human_language lcsh:RC666-701 Heart failure language Population study Cardiology and Cardiovascular Medicine business Research Article |
Zdroj: | Cardiology Research and Practice, Vol 2018 (2018) Cardiology Research and Practice Volume 2018 |
ISSN: | 2090-0597 2090-8016 |
Popis: | Aims. The Cardiac Resynchronization Therapy (CRT) Survey II was conducted between October 2015 and December 2016 and included data from 11088 CRT implantations from 42 countries. The survey’s aim was to report on current European CRT practice. The aim of this study was to compare the Croatian national CRT practice with the European data. Methods. Five centres from Croatia recruited consecutive patients, in a 15-month period, who underwent CRT implantation, primary or an upgrade. Data were collected prospectively by using online database. Results. A total of 115 patients were included in Croatia, which is 33.2% of all CRT implants in Croatia during the study period (total n=346). Median age of the study population was 67 (61–73) years, and 21.2% were women. Primary heart failure (HF) aetiology was nonischemic in 61.1% of patients, and HF with wide QRS was the most common indication for the implantation (73.5%). 80% of patients had complete left bundle branch block, and over two-third had QRS ≥150 ms. Device-related adverse events were recorded in 4.3% of patients. When compared with European countries, Croatian patients were significantly younger (67 vs. 70 years, p=0.012), had similar rate of comorbidities with the exception of higher prevalence of hypertension. Croatian patients significantly more often received CRT-pacemaker when compared with European population (58.3 vs. 29.9%, OR 3.27, 95%CI 2.25–4.74, p<0.001). Conclusion. Our data indicate strict selection of patients among HF population and adherence to guidelines with exception of higher proportion of CRT-pacemaker implantation. This is likely to be influenced by healthcare organization and reimbursement issues in Croatia. |
Databáze: | OpenAIRE |
Externí odkaz: |